Characterization of Interventricular Conduction Measurements
NCT ID: NCT01362465
Last Updated: 2012-09-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
EARLY_PHASE1
25 participants
INTERVENTIONAL
2011-06-30
2012-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Stimulus Intensity in Left Ventricular Leads
NCT01060449
Empiric Versus Imaging Guided Left Ventricular Lead Placement in Cardiac Resynchronization Therapy
NCT01323686
Wireless Stimulation Endocardially for Cardiac Resynchronization Therapy
NCT01294527
Evaluation of Left Ventricular (LV) Lead Positioning Using MediGuide
NCT01917266
Conduction System Vs Surgical Left Ventricular Epicardial Pacing For Coronary Sinus Lead Failure
NCT06342492
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Cardiac Resynchronization Therapy (CRT)
Implanting device to measure delays between paced chambers in heart failure patients.
Cardiac Resynchronization Therapy
Implanting device to measure delays between paced chambers in heart failure patients.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Cardiac Resynchronization Therapy
Implanting device to measure delays between paced chambers in heart failure patients.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* The patient or the patient's legally authorized representative is willing to give informed consent.
* CRT indicated guidelines.
* Patient is receiving a Medtronic IPG or ICD.
Exclusion Criteria
* Patient is in AF.
* Patient with 3rd degree AV block.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Medtronic
INDUSTRY
Medtronic Cardiac Rhythm and Heart Failure
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Brett Atwater, MD
Role: PRINCIPAL_INVESTIGATOR
Durham VA
Robert Hoyt, MD
Role: PRINCIPAL_INVESTIGATOR
Catholic Health Initiative Iowa Corp
Eric E Johnson, MD
Role: PRINCIPAL_INVESTIGATOR
Sterns Cardiovascular Foundation
John F Beshai, MD
Role: PRINCIPAL_INVESTIGATOR
University of Chicago
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
TDSICM
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.